Observational Trial of Real-World Treatment Utilization and Effectiveness of PI3K-inhibitors in CLL/SLL and FL
Public ClinicalTrials.gov record NCT04342117. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
PI3K-Inhibitor Registry Study: Real-World Treatment Utilization and Effectiveness of PI3K-inhibitors in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will assess whether there are differences in effectiveness and safety outcomes among PI3K-treated patients in a real world registry, compared to patients treated in clinical trials.
Study identification
- NCT ID
- NCT04342117
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 2 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 22, 2020
- Primary completion
- Dec 30, 2020
- Completion
- Dec 30, 2020
- Last update posted
- Mar 16, 2021
2020
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| CARTI Cancer Center | Little Rock | Arkansas | 72205 | — |
| Joliet Oncology-Hematology Associates, LTD | Joliet | Illinois | 60435 | — |
| Goshen General Hospital | Goshen | Indiana | 46526 | — |
| McFarland Clinic,PC | Ames | Iowa | 50010 | — |
| St. Agnes Hospital | Baltimore | Maryland | 21229 | — |
| Regional Cancer Care Associates LLC | Bethesda | Maryland | 20817 | — |
| Hattiesburg Clinic, PA | Hattiesburg | Mississippi | 39401 | — |
| Capital Region Medical Center | Jefferson City | Missouri | 65101 | — |
| Oncology Hematology Associates | Springfield | Missouri | 65807 | — |
| NY Cancer and Blood Specialists | Port Jefferson Station | New York | 11776 | — |
| University of Wisconsin Hospital and Clinics | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04342117, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 16, 2021 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04342117 live on ClinicalTrials.gov.